Stem Cell Agency Evaluation Subcommittee Meeting April 19, 2011

Apr 19, 2011
Main Location: 

CIRM
210 King Street
San Francisco, CA 94107

Additional Locations: 
8170 Laguna Blvd., #215 Elk Grove, CA 95758
The Sherry Lansing Foundation 2121 Avenue of the Stars, Suite 2020 Los Angeles, CA 90067
Klein Financial Corporation 550 California Avenue, Suite 330 Palo Alto, CA 94306
Onyx Pharmaceuticals, Inc. 2100 Powell Street Emeryville, CA 94608
ValleyCare Health System 5575 West Las Positas Blvd. Suite 300 Pleasanton, CA 94588
San Francisco City Attorney's Office San Francisco International Airport International Terminal, 5th Floor San Francisco, CA 94128

Stem Cell Agency Evaluation Subcommittee Meeting
MEETING NOTICE AND AGENDA

REGULAR TELECONFERENCE MEETING
EVALUATION SUBCOMMITTEE
OF THE INDEPENDENT CITIZENS OVERSIGHT COMMITTEE
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE

Organized Pursuant to the
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Open Session

1. Call to Order.

2. Roll Call.

Closed Session
3. Discussion of Personnel [Discussion of potential candidates for Chair] (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(f) (3) (D)).

Open Session
4. Public Comment.

5. Adjournment.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizen’s Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizen’s Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

© 2013 California Institute for Regenerative Medicine